ELOCTATE
NDC 71104-802, Antihemophilic Factor (Recombinant), Fc Fusion Protein, kit, from Bioverativ Therapeutics Inc..
- Product NDC
- 71104-802
- Status
- Listed
- Labeler
- Bioverativ Therapeutics Inc.
- Dosage form
- KIT
- Route
- INTRAVENOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125487
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71104-802 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71104-802-01 | 71104080201 | 1 KIT in 1 KIT (71104-802-01) * 3 mL in 1 VIAL (71104-484-08) * 3 mL in 1 SYRINGE (71104-035-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=71104-802
Use it
Look up 71104-802 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71104-802 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71104-802. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.